🟢 Biotricity is trading 12.08% up; specific catalyst remains unclear

Biotricity is trading at $0.05, up 12.08% on October 15, 2026; the gain’s specific catalyst remains unclear.

• No verified company-specific announcement explaining the move was found. A Bioflux deployment item in search results dates to 2018, not October 15, 2026.
• Healthcare-sector strength after UnitedHealth reported better-than-expected third-quarter earnings and raised its profit outlook offers possible supportive context.
• There is no evidence that UnitedHealth’s results directly caused Biotricity’s move.